Condition: Advanced Solid Tumor · Sponsor: AIO-Studien-gGmbH
National, retro- and prospective, observational, multicenter clinical research platform to connect clinical and genomic data of patients with advanced (locally advanced, inoperable, or metastatic) solid tumors (excluding NSCLC, SCLC, and mesothelioma) with results from multi-gene next-generation sequencing (NGS) panels (\>30 genes)
This description comes directly from the study's public registry record.
Marc Fischer · +49 30-8145344 · marc.fischer@aio-studien-ggmbh.de
Always discuss trial participation with your own doctor first.
| Praxis für interdisziplinäre Onkologie & Hämatologie | Freiburg im Breisgau, Baden-Wurttemberg, Germany | Recruiting |
| Medizinische Fakultät Mannheim der Universität Heidelberg | Mannheim, Baden-Wurttemberg, Germany | Not Yet Recruiting |
| Klinikum der Universität München | München, Bavaria, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05701150